WHO ICTRP trial

A clinical study to evaluate the use of individualized homoeopathic medicine in…

CTRI/2026/01/101743 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2026/01/101743
Public title A clinical study to evaluate the use of individualized homoeopathic medicine in improving the quality of life of gout patients aged 40 to 70 years.
Scientific title A clinical study on the efficacy of individualized homoeopathic medicine in improving the quality of life of gout patients aged 40 to 70 years using a standardized Likert scale. - NIL
Primary sponsor Parul Institute of Homoeopathy and Research Hospital
Secondary sponsors Dr Dharti Rasikbhai Patel
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: M109- Gout, unspecified
Interventions Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicine in 30,200,1m Potency, BD or TDS for 15 days for 3 months. Control Intervention1: NIL: NIL
Registration date Jan 21, 2026
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations